These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Prognostic stratification of localized renal cell carcinoma by tumor size. Bedke J; Pritsch M; Buse S; Jakobi H; Elsaesser KH; Pahernik S; Haferkamp A; Hohenfellner M J Urol; 2008 Jul; 180(1):62-7. PubMed ID: 18485376 [TBL] [Abstract][Full Text] [Related]
11. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma. Dall'Oglio MF; Ribeiro-Filho LA; Antunes AA; Crippa A; Nesrallah L; Gonçalves PD; Leite KR; Srougi M J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167 [TBL] [Abstract][Full Text] [Related]
12. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma. Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704 [TBL] [Abstract][Full Text] [Related]
13. External validation of an international multicenter study to predict survival in Korean patients with pT2N0M0 renal cell carcinoma. Ku JH; Moon KC; Kwak C; Kim HH Urology; 2009 Aug; 74(2):359-63. PubMed ID: 19501879 [TBL] [Abstract][Full Text] [Related]
14. [Pathological prognostic indicators in renal cell carcinoma]. Rey Rey J; León Ramírez D; López García S; Fernández Vázquez P; Benavente Delgado J; Ojea Calvo A Actas Urol Esp; 2010 Jan; 34(1):71-7. PubMed ID: 20223135 [TBL] [Abstract][Full Text] [Related]
15. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492 [TBL] [Abstract][Full Text] [Related]
16. Reassessment of the 1997 TNM classification system for renal cell carcinoma. Elmore JM; Kadesky KT; Koeneman KS; Sagalowsky AI Cancer; 2003 Dec; 98(11):2329-34. PubMed ID: 14635066 [TBL] [Abstract][Full Text] [Related]
17. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733 [TBL] [Abstract][Full Text] [Related]
18. [Impact of tumor size on long-term survival of patients with organ-confined renal cell cancer]. Merseburger AS; Wegener G; Horstmann M; Oelke M; Zumbrägel A; Bokemeyer C; Kollmannsberger C; Jonas U; Stenzl A; Kuczyk M Aktuelle Urol; 2003 Dec; 34(7):469-74. PubMed ID: 14655083 [TBL] [Abstract][Full Text] [Related]
19. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases. Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201 [TBL] [Abstract][Full Text] [Related]
20. Multi-institutional validation of a symptom based classification for renal cell carcinoma. Patard JJ; Leray E; Cindolo L; Ficarra V; Rodriguez A; De La Taille A; Tostain J; Artibani W; Abbou CC; Guillé F; Chopin DK; Lobel B J Urol; 2004 Sep; 172(3):858-62. PubMed ID: 15310983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]